These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35186165)

  • 1. Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis.
    Peng X; Huang Y; Zhang M; Chen Y; Zhang L; He A; Luo R
    Dis Markers; 2022; 2022():3533714. PubMed ID: 35186165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma.
    He C; Peng W; Li C; Wen TF
    Medicine (Baltimore); 2017 Nov; 96(45):e8540. PubMed ID: 29137062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
    Yang Z; Zhang J; Lu Y; Xu Q; Tang B; Wang Q; Zhang W; Chen S; Lu L; Chen X
    Oncotarget; 2015 Dec; 6(40):43090-8. PubMed ID: 26506519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.
    Chen Y; He C; Wen T; Yan L; Yang J
    Asia Pac J Clin Oncol; 2021 Oct; 17(5):e238-e248. PubMed ID: 33124200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection.
    Yang HJ; Jiang JH; Yang YT; Guo Z; Li JJ; Liu XH; Lu F; Zeng FH; Ye JS; Zhang KL; Chen NZ; Xiang BD; Li LQ
    Tumour Biol; 2017 Mar; 39(3):1010428317695944. PubMed ID: 28351330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
    Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
    Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
    Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
    Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
    Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
    Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
    Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
    J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
    Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
    BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Scores: Correlation with Clinical Outcomes in Hepatocellular Carcinoma Patients Undergoing Transarterial Radioembolization.
    Young S; Rubin N; D'Souza D; Sharma P; Pontolillo J; Flanagan S; Golzarian J; Sanghvi T
    Cardiovasc Intervent Radiol; 2022 Apr; 45(4):461-475. PubMed ID: 35178599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
    Zhang Y; Yang X
    Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.